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Estimates of heritability of psychiatric disorders quantify the genetic contribution to their
etiology. Estimation of these parameters requires affected status on probands and their
family members.Traditionally, heritabilities have been estimated from families ascertained
from specific hospital registers, but accumulating sufficient numbers of families can be
difficult. Larger sample sizes are achievable from national registries, but calculation of her-
itability from individual level data from these data sets is accompanied by other problems.
Here, we use published summary data from a national population-based cohort of >2.6
million persons in Denmark to estimate heritabilities of schizophrenia, bipolar disorder, and
major depressive disorder (MDD).The summary data comprised cumulative incidences up
to 52 years of age for schizophrenia and bipolar disorder and up to 51 years for MDD in
offspring where either one or both parents were diagnosed with one of these disorders.
Estimates of the heritabilities of the liability to developing schizophrenia, bipolar disorder,
and MDD are 0.67 (95% confidence interval (CI) 0.64–0.71), 0.62 (95% CI 0.58–0.65), and
0.32 (95% CI 0.30–0.34) respectively. The estimates may be inflated by common environ-
mental effects, but despite this, they are somewhat lower for schizophrenia and bipolar
disorder than those estimated from contemporary twin samples. The lower estimates
may reflect the diverse environments (including diagnostic interpretation) that contribute
to national data, compared to twin/family studies. Our estimates are similar to those esti-
mated previously from national data of Sweden, and they may be more representative
of the international samples brought together for large-scale genome-wide association
studies. We investigated the estimation of genetic correlations from these data. We used
simulation to conclude that estimates may not be interpretable and so report them only in
the Section “Appendix.”
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INTRODUCTION
Twin and family studies of schizophrenia, bipolar disorder, and
major depressive disorder (MDD) have demonstrated a major
genetic contribution to the etiology of these common complex
disorders (Sullivan et al., 2000; McGuffin et al., 2003; Kirov
and Owen, 2009), and this contribution is quantified through
estimates of heritability to their liability. The current genera-
tion of genome-wide association studies (GWAS) have identi-
fied specific variants, both common and rare, associated with
these disorders (Purcell et al., 2009; Ripke et al., 2011; Sklar
et al., 2011; Psychiatric GWAS Consortium for Major Depres-
sive Disorder, 2012), but together these explain only a frac-
tion of the heritability identified from family studies (Visscher
et al., 2012). The puzzle of this so-called “missing heritabil-
ity” (Maher, 2008) is not limited to neuropsychiatric disorders,
but is a characteristic of studies of almost all complex genetic
traits, diseases, and disorders. One contributing explanation
may be overestimation of heritabilities from twin and family
studies.
Just as estimates of heritability benchmark the maximum con-
tribution to the variance we expect to achieve through direct inter-
rogation at the molecular level, genetic correlations benchmark
the relationship between disorders. Estimates of heritabilities and
genetic correlations of liability, although quite simple in theory
(Visscher et al., 2008), depend on estimates of lifetime probabili-
ties of disease in relatives of affected individuals and from the total
population from which they are drawn. Quantifying the genetic
contribution to disease is achieved by assuming the liability thresh-
old model (Falconer, 1965); under this model, liability to disease
(which includes both genetic and environmental effects) is con-
sidered to be normally distributed, with affected individuals being
those with liabilities greater than the threshold that truncates the
proportion with the disorder in the population. The liability model
can be shown to be exchangeable with a wide range of other models
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that are also consistent with empirical data (Slatkin, 2008), but its
parameterization makes it the model of choice for theoretical and
applied studies. This liability threshold model was first applied to
schizophrenia psychopathology by Gottesman and Shields (1967)
having consulted with Douglas Falconer in 1965 in Edinburgh on
the validity of their extrapolations to psychiatric diseases. Many
estimates of heritability have been made from twin samples or
extended family studies (reviewed for schizophrenia; Cardno and
Gottesman, 2000; Sullivan et al., 2003). A limitation of these stud-
ies is that families ascertained from specific hospital registers may
not be a representative sample of the population used to get over-
all probability rates (Kendler et al., 1995), for example if different
diagnostic criteria are used for the family sample compared to
the total reference population. Further, family samples tend to be
small implying large sampling variances, and rates may be biased
upward if there are any ascertainment biases (Odegard, 1963; Guo,
1998) or if diagnoses of family members are more highly cor-
related than if family members presented at different hospitals.
These problems can be overcome by using national data, where
available, such as in a Swedish study comprising over nine million
individuals from over two million families which represented all
individuals born between 1932 and 2002 and all hospital records
since 1973 (Lichtenstein et al., 2009).
However, use of national registries brings its own problems
(Mortensen et al., 2010) from routinely recorded clinical diag-
noses collected into dynamic data-bases of records necessarily
censored given the age structure of the population and varying
ages of onset for the disorders. The Swedish study (Lichtenstein
et al., 2009) matched schizophrenia and bipolar probands on age
and sex with unaffected controls as a way to overcome problems of
censored data. In that study, estimates of heritabilities and genetic
correlations were achieved through development of generalized
linear mixed models for binary bivariate data applied to individ-
ual level data (Yip et al., 2008). Their estimates of heritabilities
were lower than those traditionally quoted for schizophrenia [0.64
(95% confidence interval (CI) 0.62–0.68) vs. 0.81 (95% CI 0.73–
0.90); Sullivan et al., 2003] and bipolar disorder [0.59 (95% CI
0.56–0.62) vs. 0.85 (95% CI 0.73–0.93); McGuffin et al., 2003]. As
a stand-alone study, it is difficult to evaluate the importance of
these differences, but estimates of heritability from national data
may be of most relevance to the international samples brought
together in large GWAS studies.
Another study that used national data to investigate increased
risks of schizophrenia and bipolar in offspring of affected parents
was the study from Denmark of Gottesman et al. (2010), which
particularly focused on a rare sample of offspring with two affected
parents. To account for censorship in lifetime estimates of proba-
bility of disease, they calculated the increased risks of disease from
cumulative incidences of disease across ages, well into their risk
periods. Analysis of these records accounting for censorship in a
mixed model framework to estimate genetic parameters would be
complex. The framework of the liability model, as proposed by Fal-
coner (1965), is of estimation of heritability from recurrence risk
to relatives estimated from the population, even though at the time
such population estimates were not available. Here, we implement
that framework to provide estimates of heritability for psychiatric
disorders from nationally collected records. We use population
summary statistics, i.e., cumulative incidences from the large Dan-
ish study (>2.6 million records) to estimate heritabilities of schiz-
ophrenia, bipolar disorder, and MDD. To demonstrate the validity
of the approach we apply these methods to the summary statistics
from the Swedish study and show that the resulting estimates of
heritability agree well with their estimates derived from full data
modeling (Lichtenstein et al., 2009). Originally, our interest was to
use the Danish summary data to estimate the genetic correlation
between schizophrenia and bipolar disorder and, between schizo-
phrenia and MDD, since few studies have been able to quantify this
relationship. We explored this aim, but using simulation to repre-
sent important characteristics of the summary data available, we
concluded that the estimates could not be considered reliable and
so report them only in the Section “Appendix.”
MATERIALS AND METHODS
DESCRIPTION OF DATA GENERATING PUBLISHED SUMMARY
STATISTICS
We use the summary statistics calculated from population-based
cohort reported in Gottesman et al. (2010). Briefly, the cohort
comprises all persons born in Denmark, alive in 1968 or born
between 1969 and 1996 who could be linked to their parents
through the Civil Registration System (N = 2,685,301). Those who
had ever received diagnoses of schizophrenia or bipolar affective
disorder or unipolar depressive disorder from a psychiatric facility
between April 1 1970 and January 1 2007 were identified from the
Psychiatric Central Register according to diagnoses at discharge
from admissions to all inpatient facilities and from out-patient
treatment facilities for admissions from 1995 onward. All admis-
sions in Denmark are contained in the register, as there are no
private psychiatric inpatient or outpatient units (Gottesman et al.,
2010). Diagnostic classification was based on the International
Classification of Disease, Eighth Revision (ICD-8) from 1966 to
1993 and on the 10th revision (ICD-10) since then (Gottesman
et al., 2010). Here we use the nomenclature of MDD rather than
unipolar depressive disorder. Those discharged more than once
with different diagnoses were counted in more than one diagnos-
tic group after unsuccessful trials with alternative ascertainments
(Gottesman et al., 2010).
CUMULATIVE INCIDENCES
The incidence of psychiatric admission was calculated from the
number of new cases occurring for each age in the cohort mem-
bers. Gottesman et al. (2010) reported cumulative incidences up
to a maximum of age 52 for schizophrenia and bipolar disorder, an
age well into the accepted risk period for these disorders. Cumula-
tive incidences were based on the Nelson–Aalen estimator, which
is a cumulative hazard rate function appropriate for censored and
incomplete data. The cumulative incidences to age 52 can be inter-
preted as the proportion of people in the population who have/will
received a diagnosis by age 52 (Gottesman et al., 2010). Cumu-
lative incidences were calculated for different cohorts including:
the general population (no restriction on psychiatric diagnosis of
parents), and the offspring of parents where one or both parents
had a psychiatric diagnosis. The number of unique parent cou-
ples (counted only once) was 1,278,977, some of whom had more
than one offspring. Here we utilize the cumulative incidences to
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estimate genetic parameters. For MDD, the authors of Gottesman
et al. (2010) provided estimates of the cumulative incidences up to
a maximum of age 51, unpublished results from their preliminary
analyses. Gottesman et al. (2010) showed that cumulative inci-
dences had plateaued by age 52 for schizophrenia, but they were
still rising for bipolar disorder.
METHODS FOR ESTIMATION OF HERITABILITIES, GENETIC
CORRELATIONS, AND THEIR STANDARD ERRORS
We adapted the methods of Falconer (1965) and Reich et al.
(1972) to estimate heritabilities of schizophrenia, bipolar disor-
der, and MDD (h2SCZ, h
2
BPD, and h
2
MDD, respectively), the genetic
correlation between disorders and their standard errors. These
methods are based on the liability threshold model in which a
normal distribution of liability is assumed to underlie affection
status and those affected have liability that surpasses a critical
threshold. The liability is unobserved but the threshold can be
determined from normal distribution theory given the propor-
tion of the population that are affected in their lifetime. The
proportions affected in the population and in relatives of those
affected are used to estimate heritability of liability (Falconer and
Mackay, 1996; Lynch and Walsh, 1998). Here we use cumulative
incidence to 52 or 51 years as estimates of the proportion of the
population that are affected in their lifetime. Critical assump-
tions associated with these widely used methods are discussed
below. Corrections for non-normality in the relatives are negligible
(Lynch and Walsh, 1998) and are not considered here. We estimate
h2SCZ twice: from the prevalence of schizophrenia in offspring
where one parent has schizophrenia and from the prevalence of
schizophrenia in offspring where both parents had schizophrenia;
and likewise for bipolar disorder and MDD. We obtain overall esti-
mates by weighting the individual estimates by the inverse of their
sampling variances. Full derivations are provided in the Section
“Appendix.”
SIMULATION TO INVESTIGATE ESTIMATES FROM GENETIC
CORRELATIONS FROM THE DANISH SUMMARY DATA
In the Danish summary data used in our analysis, those dis-
charged more than once with different diagnoses were counted
in more than one diagnostic group, a non-hierarchical approach.
It is widely recognized that many patients do not have disorders
that conform to discrete diagnostic classes (Craddock and Owen,
2007) and that some individuals may be truly co-morbid. None-
the-less long-term stable diagnoses are considered more reliable
than first episode diagnosis (Bromet et al., 2011). Laursen et al.
(2009) reported the frequency of individuals receiving multiple
diagnoses within their lifetime using the Danish registry data
(>2.5 million persons born in Denmark after 1954). From their
Table 1, of 16,890 first admissions of bipolar disorder, schizo-
phrenia, or schizoaffective disorder, we calculate that 2.8% of the
12,458 with a final diagnosis of schizophrenia had also been diag-
nosed with bipolar disorder and 7.1% of the 3,862 with a final
diagnosis of bipolar disorder had also been diagnosed with schiz-
ophrenia. Also, 4.9% of those who ever received a diagnosis of
schizophrenia and 15% of those who ever received a diagnosis
of bipolar disorder also received a diagnosis of the other disor-
der. These raw estimates do not account for censoring (i.e., some
individuals may not have yet received their stable diagnosis) and
so may be underestimates. We were concerned that the counting
of individuals across multiple diagnostic classes (double counting)
could bias the estimates of genetic parameters, particularly genetic
correlations. The impact of misdiagnosis on estimates of genetic
parameters has been explored before (Kendler, 1987; Wray et al.,
2012), but these studies assumed individuals were counted in a
single, possibly incorrect, diagnostic class. We extended the simu-
lation of (Wray et al., 2012) to consider individuals being counted
in more than one diagnostic class. We simulated 100,000 nuclear
pedigrees of two parents and one child under a liability thresh-
old model for two independent disorders (i.e., genetic correlation
zero). The input parameters were heritabilities and prevalence
rates of the two disorders. We also specified the probability of
an individual affected with disorder A, also being diagnosed with
disorder B, and vice versa. According to these rates, a propor-
tion of cases were randomly assigned affected status for the other
disorder. Within the simulation we estimated the heritabilities
and genetic correlation based on prevalence diagnosis rates in
the parents and in the offspring of affected parents. True sim-
ulation parameters were set so that estimated prevalence rates
and heritabilities matched those from the empirical results. We
repeated each simulation scenario 100 times to achieve approxi-
mate 95% CIs (5th and 95th percentile simulation results) on the
estimates.
RESULTS
VALIDATION OF METHODS
To check the validity of our methods of estimating genetic para-
meters from summary data, we used the Swedish population
prevalences and recurrence risk ratios listed in Lichtenstein et al.
(2009) to estimate the genetic parameters. We compared these
estimates to their estimates based on mixed model methodology
that used individual level data (Table 1). Our estimates compared
to the published estimates were: 0.64 (95% CI 0.61–0.67) vs. 0.64
(95% CI 0.62–0.68) for h2SCZ and 0.56 (95% CI 0.54–0.58) vs. 0.59
(95% CI 0.56–0.62) for h2BPD. The overlapping confidence inter-
vals between these estimates justified our approach, recognizing
that the good agreement partly reflects that the full partitioning
of variance analyses in the original study found only estimates
of common environmental variance to be significant but small
0.045 (95% CI 0.044–0.074) for schizophrenia and 0.034 (95% CI
0.023–0.062) for bipolar disorder.
ESTIMATES OF HERITABILITY
Using the cumulative incidences of disease to age 52 estimated
from national records of Denmark, we calculate h2SCZ to be 0.67
(95% CI 0.64–0.71), h2BPD to be 0.62 (95% CI 0.58–0.65), and
h2MDD to be 0.32 (95% CI 0.30–0.34; Table 2). For both MDD and
bipolar disorder the heritability estimated from disorder proba-
bilities in offspring with both parents affected was slightly higher
than when only one parent was affected, a pattern that might be
consistent with confounding of common environmental effects
or non-additive genetic effects, but the estimates were not sig-
nificantly different. For schizophrenia the estimate of heritability
when both parents were affected was less than when only one
parent was affected, but not significantly so.
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Table 1 | Validation of approach: estimation of heritabilities using probability estimates and recurrence risk ratios presented in Lichtenstein
et al. (2009).
Child Parents Probability estimate 95% CI
SCZ ALL 0.00399 0.00395–0.00404a
BPD ALL 0.00449 0.00450–0.00454a
Relatives Proband Recurrence risk ratio 95% CI Probability estimate 95% CI h2 95% CI
SCZ offsp SCZ 9.9 8.5–11.6 0.0395 0.0333–0.0457 0.67 0.62–0.72
SCZ Full-sib SCZ 9.0 8.1–9.9 0.0360 0.0323–0.0395 0.63 0.60–0.66
SCZ MHS SCZ 3.6 2.3–5.5 0.0144 0.0078–0.0208 0.67 0.43–0.90
SCZ PHS SCZ 2.7 1.9–3.8 0.0108 0.0070–0.0146 0.50 0.32–0.68
Heritability of schizophrenia weighted mean 0.64 0.61–0.67
Heritability of schizophrenia as reported in Lichtenstein et al 0.64 0.62–0.68
BPD offsp BPD 6.4 5.9–7.1 0.0288 0.0261–0.0315 0.53 0.50–0.56
BPD Full-sib BPD 7.9 7.1–8.8 0.0355 0.0317–0.0393 0.60 0.57–0.64
BPD MHS BPD 4.5 2.7–7.4 0.0202 0.0097–0.0308 0.83 0.53–1.12
BPD PHS BPD 2.4 1.4–4.1 0.0108 0.0047–0.0169 0.45 0.16–0.74
Heritability of bipolar disorder weighted mean 0.56 0.54–0.58
Heritability of bipolar disorder as reported in Lichtenstein et al 0.59 0.56–0.62
a95% CI=K±1.96 √K (1− K )/N , where K is the prevalence estimate, and N=9,009,202, the total sample size.
All values in bold were provided in (Lichtenstein et al., 2009). SCZ, schizophrenia; BPD, bipolar disorder; offsp, offspring; MHS, Maternal half sibs; PHS, Paternal half
sibs.
Table 2 | Estimates of heritabilities based on the data presented in Gottesman et al. (2010).
Child Parents Prevalencea 95% CI h2 95% CI
SCZ ALL 0.0112 0.0109–0.0114
BPD ALL 0.0063 0.0060–0.0066
MDD ALL 0.0415 0.0408–0.0422
SCZ SCZ/- 0.07 0.064–0.077 0.67 0.64–0.71
SCZ SCZ/SCZ 0.273 0.183–0.362 0.65 0.55–0.76
Weighted mean heritability of schizophrenia (h2SCZ) 0.67 0.64–0.71
BPD BPD/- 0.044 0.040–0.049 0.61 0.58–0.65
BPD BPD/BPD 0.2495 0.140–0.358 0.66 0.54–0.79
Weighted mean heritability of bipolar disorder (h2BPD) 0.62 0.58–0.65
MDD MDD/- 0.078 0.075–0.081 0.31 0.29–0.33
MDD MDD/MDD 0.162 0.138–0.187 0.36 0.31–0.41
Weighted mean heritability of MDD (h2MDD) 0.32 0.30–0.34
aFor schizophrenia (SCZ) and bipolar disorder (BPD) the prevalence estimates are the cumulative incidence of disease to age 52 and the 95% CI confidence intervals
(95% CI) provided at the level of significance reported in Gottesman et al. (2010). For MDD the prevalence estimates are the cumulative incidence of disease to age
51, provided to us by the authors of (Gottesman et al., 2010).
USING SIMULATION TO EXPLORE ESTIMATION OF GENETIC
CORRELATION
Our calculations are based on the summary statistics estimated
from the Danish National Register in which individuals were
included in more than one diagnostic class if their hospital dis-
charge records across their lifetime reflected multiple diagnoses.
We used simulation to explore the impact of including a propor-
tion of individuals in more than one diagnostic class (one true
and one misdiagnosed) on estimates of heritabilities and genetic
correlation for schizophrenia and bipolar disorder (Table 3).
Without misdiagnosis, the simulation returned estimated her-
itabilities and genetic correlation that matched the simulation
parameters (Table 3 row 1), as expected. With misdiagnosis rates
of 2.7% for schizophrenia and 7.1% for bipolar disorder (chosen to
match our estimates calculated from; Laursen et al., 2009) true her-
itabilities were slightly higher (and true prevalence rates slightly
lower) than those estimated, but not dramatically so. However,
in line with results of (Wray et al., 2012), the misdiagnosis and
double counting generated an estimated genetic correlation was
0.17 (Table 3 row 2), even though the true correlation was set to
Frontiers in Genetics | Applied Genetic Epidemiology July 2012 | Volume 3 | Article 118 | 4
Wray and Gottesman Heritabilities for schizophrenia, bipolar disorder, and MDD
Table 3 | Simulation results: simulation parameters were selected to generate estimated diagnosis prevalence rates and heritabilities that
match empirical estimates for schizophrenia (SCZ) and bipolar disorder (BPD).
True (simulation) parameters Estimated parameters (95% Confidence intervals)
Prevalence h2 Misdiagnosis rate
both diagnoses counted
rg Proportion with alternate diagnosis
SCZ BPD SCZ BPD SCZ BPD SCZ BPD
1 0.0112 0.0063 0.67 0.62 0 0 0.00 (−0.07–0.07) 0.006 (0.006–0.007) 0.011 (0.010–0.013)
2 0.0108 0.0060 0.68 0.64 0.028 0.071 0.17 (0.13–0.24) 0.070 (0.067–0.072) 0.125 (0.119–0.129)
3 0.0104 0.0057 0.70 0.66 0.056 0.142 0.31 (0.26–0.35) 0.128 (0.125–0.131) 0.228 (0.222–0.234)
In all simulations the estimated diagnosis prevalence rates are 0.0112 and 0.0063, and estimated heritabilities are 0.67 and 0.62, for SCZ and BPD respectively. Even
under analysis 3 the 95% CI for the estimated heritabilities were only 0.65–0.69 for SCZ and 0.58–0.64 for BPD.
zero. This scenario also resulted in 7.0% of those with a diagnosis
of schizophrenia and 12.5% of those with a diagnosis of bipo-
lar disorder also having a diagnosis of schizophrenia. Recognizing
that the misdiagnosis rates calculated from (Laursen et al., 2009)
data may underestimate dual diagnosis rate as some cases may not
yet have achieved their final diagnosis, we repeated the simulations
with misdiagnosis rates increased twofold. These extreme misdiag-
nosis rates generated an estimated genetic correlation of 0.31 when
the true correlation was zero (Table 3 row 3) and again reflected
slightly higher true heritabilities. The simulations also confirmed
that the 95% CI for the genetic correlations are considerably wider
than those for heritabilities. We conclude from these simulations
that our estimates of heritability from the Danish summary data
may be slightly lower than the true values as a result of the double
counting of individuals across diagnostic classes, but not consider-
ably so. We also concluded that the estimates of genetic correlation
are consistent with a true underlying positive genetic correlation
between both schizophrenia and bipolar disorder and schizophre-
nia and MDD, the double counting, and other assumptions would
make estimates of genetic correlation from the Danish summary
data impossible to interpret, and so report them only in the Section
“Appendix.”
DISCUSSION
Heritabilities of schizophrenia, bipolar disorder, and MDD esti-
mated from published summary data from Danish national
records are h2SCZ = 0.67 (95% CI 0.64–0.71), h2BPD = 0.62 (95%
CI 0.58–0.65), and h2MDD = 0.32 (95% CI 0.30–0.34; Table 2).
The estimates of heritability are low compared to the estimates
commonly quoted for schizophrenia [0.81 (95% CI 0.73–0.90);
Sullivan et al., 2003] and bipolar disorder [0.85 (95% CI 0.73–
0.93); McGuffin et al., 2003] but are similar to the estimates from
the Swedish study of national records (Lichtenstein et al., 2009):
0.64 (95% CI 0.62–0.68) for schizophrenia and 0.59 (95% CI 0.56–
0.62) for bipolar disorder. Lower estimates from national samples
may reflect an effect of averaging across “nosological environ-
ments”such as diagnostic interpretation, which is likely to be more
homogeneous in within-hospital twin studies than in national
data. The ever-increasing size of samples used in GWAS necessarily
combine cohorts with different collection protocols (e.g., diagnos-
tic criteria and their local applications), and therefore, the lower
estimates of heritability may be more representative of popula-
tion samples. The estimate of heritability for MDD is in line with
the estimate from a meta-analysis of twin studies [0.37 (95% CI
0.31–0.42); Sullivan et al., 2000] where many of the contribut-
ing estimates were from very large community samples of twins.
Lewis et al. (2010) argued that major depression cases ascertained
through clinical contact are more severe and tend to have stronger
genetic contribution than cases diagnosed by lay interviewers in
the general population since the heritability of MDD from a large
hospital sample ranged from 0.48 to 0.75 [depending on the model
fitted to the 177 twin pairs (McGuffin et al., 1996)]. The MDD
cases contributing to the summary data used here are recorded
from psychiatric in- and out-patient units and so may be consid-
ered severe, in which case our estimate of heritability for MDD is
also lower than those estimated from data collected from limited
hospital environments.
Despite a classification system that considers schizophrenia and
bipolar disorder to be distinct, this dichotomy has long been ques-
tioned by empirical observations (Craddock and Owen, 2005;
Craddock et al., 2006; Van Snellenberg and de Candia, 2009) which
includes the relatively common occurrence of cases with a mix
of mood and psychotic symptoms and families with multiple
cases of both disorders (Pope and Yurgeluntodd, 1990; Black-
wood et al., 2001; McGuffin et al., 2003; Cardno et al., 2012).
Molecular studies support a partially shared genetic etiology of
bipolar disorder and schizophrenia (Moskvina et al., 2009; Pur-
cell et al., 2009), but only few studies (to our knowledge) have
directly estimated the genetic correlation between schizophrenia
and bipolar disorder (Yip et al., 2008; Lichtenstein et al., 2009; or
schizophrenic and mania syndromes; Cardno et al., 2002). Depres-
sion is frequently co-morbid with schizophrenia, for example 31%
of 90 patients with a stable diagnosis of schizophrenia were found
to qualify for a diagnosis of depression (Majadas et al., 2012).
However, overlapping symptoms of disorders does not necessar-
ily imply a shared genetic etiology (Klein and Riso, 1993; Neale
and Kendler, 1995). Increased risks for MDD in relatives of those
with schizophrenia have been reported, e.g., (Maier et al., 1993;
Varma et al., 1997; Mortensen et al., 2010), but it is difficult to
separate the impact of shared environment from the genetic com-
ponents, since psychiatric disorders impact on the lives of family
members. We were unable to identify studies that had estimated
www.frontiersin.org July 2012 | Volume 3 | Article 118 | 5
Wray and Gottesman Heritabilities for schizophrenia, bipolar disorder, and MDD
the genetic correlation between schizophrenia and major depres-
sion. For these reasons we were motivated to estimate genetic
correlations between schizophrenia and both bipolar disorder and
MDD. However, the collation of the Danish summary data counted
individuals in multiple diagnosis categories if their hospital dis-
charge records offered different diagnoses over time. Misdiagnosis
between disorders inflates estimates of genetic correlations (Wray
et al., 2012). Using simulation we found that this double counting
of diagnoses could generate marginal underestimates of heritabil-
ity (by up to 4%), but could generate considerable overestimates
of the genetic correlation when the true genetic correlation is zero.
We believe that the empirical estimates are consistent with a pos-
itive genetic correlation between both schizophrenia and bipolar
disorder and between schizophrenia and MDD, but concluded that
the estimates of genetic/familial correlations from these summary
data could be misleading and so report them only in the Section
“Appendix.”
ASSUMPTIONS AND LIMITATIONS
Our analysis required a number of important assumptions and
our results must be interpreted with caution recognizing the inher-
ent limitations of our study, as in most studies estimating genetic
parameters. Firstly, we have assumed the Falconer liability model
for disease. This model is particularly suited to an etiology of
many underlying risk factors and is used in all other studies esti-
mating heritability from binary disease records, and results from
GWAS provide no evidence to reject this model (Purcell et al.,
2009; Lee et al., 2012). Secondly, we have assumed that increased
risk to relatives reflects only genetic factors and have ignored com-
mon environmental factors, therefore our estimates of heritability,
strictly speaking, are estimates of familial transmission. However,
published estimates of variance attributable to a common family
environment suggest that these effects are small (McGue et al.,
1983; Sullivan et al., 2000, 2003), as discussed above. Since we are
not able to account for common family environment our esti-
mates of heritability may be slightly inflated, but even so, our
estimates are lower than those usually reported for schizophrenia
and bipolar disorder. Thirdly, as in all other studies using close
relatives, non-additive (epistatic) genetic effects may inflate the
estimates attributed to additive genetic effects. Fourthly, we have
used estimates of cumulative incidences at 52 years as the esti-
mates of lifetime probability of disease. We note that although the
cumulative incidences had plateaued by age 52 for schizophrenia
they were still rising for bipolar disorder. For MDD cumulative
incidences are also likely to increase beyond 51 years. Therefore,
incidences cumulated to older ages may impact on our results
but since we have used the same definition across all cohorts the
impact on the estimates of genetic parameters will be limited.
Fifthly, changes in diagnostic practice over time may impact esti-
mates of cumulative incidence in offspring compared to parents
and hence bias estimates. Sixthly, as discussed above, misdiagno-
sis between disorders could result in our estimates of heritability
being slightly lower than true values in the population, but that this
cannot account for the difference between our estimates and the
higher estimates reported from twin studies. Lastly, in our use of
the liability threshold model we have assumed that genetic liability
variance is constant across generations. Specifically, we ignored
the reduced fertility of those with both bipolar disorder (Baron
et al., 1982) and schizophrenia (Svensson et al., 2007); for example
using the Danish registry data Laursen and Munk-Olsen (2010)
estimated that the relative risk of having a child for women with
hospital admissions for schizophrenia, bipolar disorder, and MDD
compared to individuals never admitted with any psychiatric diag-
nosis were was 0.18 (95% CI 0.17,0.20), 0.36 (95% CI 0.33–0.40)
and 0.57 (95% CI 0.55,0.60), respectively. Reduced fertility and
fecundity could reduce genetic variance from one generation to
the next. However, we have also ignored assortative mating which
would increase genetic variance across generations. Assortative
mating can be calculated from the data provided in the Danish
study (Gottesman et al., 2010) as a relative risk to spouse of 2.13
for schizophrenia and 1.09 for bipolar disorder, much less than the
estimate reported in the Swedish national cohort ∼8 for schizo-
phrenia (Lichtenstein et al., 2006). Accurate modeling of genetic
variance across generations would require good estimates of fer-
tility, fecundity, assortative mating, and a net decrease/increase in
genetic variance could imply decrease/increase in lifetime proba-
bility of disease. Without better empirical data it seems reasonable
to assume that these forces on genetic variance balance each other
and to assume equality of parameters across generations, as in
other studies.
CONCLUSIONS
We provide estimates of heritabilities derived from cumulative
incidences estimated from the National Danish Registry of over
2.6 million individuals. Only one other study has published genetic
parameters from national data (a Swedish study; Lichtenstein et al.,
2009). Our estimates of heritability for schizophrenia and bipolar
disorder, like theirs, are lower than the traditionally quoted esti-
mates,which are based on small samples of relatives (usually twins)
usually from single hospital environments. Our estimates may be
more relevant to the large samples that make up the consortia that
underpin the current generation of GWAS (Cichon et al., 2009).
Estimates of increased risk to disease in relatives, which are
straightforward in principle,are difficult to collect in practice. Here
we show that cumulative incidence summary statistics calculated
from national data can be used to estimate heritabilities. Evidence
for a shared genetic etiology between disorders could make impor-
tant contributions to psychiatric nosology. However, very large
cohorts of twin and family samples, ascertained without bias and
recorded for multiple disorders would be needed to estimate the
genetic correlation between disorders. Not surprisingly, such stud-
ies are difficult to achieve (Cardno et al., 2012) and hence are
limited. The use of regional or national data seems the only way to
achieve sufficient sample sizes, but these data sets have their own
challenges. Here, we were not able to estimate genetic correlations
that we considered reliable. The new era of genome-wide genotype
data provides perhaps our best hope of understanding the shared
etiology of psychiatric disorders (Lee et al., 2011). Such estimates
are derived using independently collected cases and controls for
the two disorders and estimates are based on such distant rela-
tives that contamination by shared environmental factors seems
unlikely.
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APPENDIX
ESTIMATION OF HERITABILITIES AND GENETIC CORRELATIONS
(I) Relatives are affected with the same disorder as probands.
We define K as the lifetime probability of disease (or preva-
lence of a disease) in the population. Under the liability threshold
model, those with phenotypic liability, Z ∼ N (0,1), greater than
the threshold T are diseased such that distribution p(Z >T )=K.
Falconer (1965) in his Model 1 showed that the threshold in
relatives (TR) is expected to be
TR = T − aR ih2 (A1)
where aR is the additive genetic relationship between the relatives
i is the mean liability of the diseased group in the population,
calculated as i= y/K where y is the height of the normal curve at
threshold T. Since TR can be calculated from the observed proba-
bility of disease in the relatives,KR (andKR>K, thereforeTR<T ),
heritability can be estimated as
h2 = T − TR
aR i
Falconer (1965) derived the approximate standard error of the
estimate of the heritability,
s.e ≈ 1
aR
√√√√[K 2
y2
(
1
i
+ aRh2 (i − T )
)2
+ K
2
R
i2y2R
]
, (A2)
where the variance of the estimate of the truncation threshold is
V (T )=K 2/y2 and likewise for V (TR).
Reich et al. (1972), showed that although Eq. A1 accounts
for the mean liability of the relative group given the affected
probands, it does not account for the reduced variance in this
group compared to the general population which results from the
conditioning on the proband disease status. Therefore, the equal-
ity inEq. A1 needs to be standardized to return it to a N (0,1)
distribution,
TR = T − aR ih
2√
1− a2Rh4i (i − T )
(A3)
Rearrangement of this equation provides an estimate of the heri-
tability of liability based on the directly measurable parameters of
population prevalence of disease (K ) and the recurrence risk ratio
in relatives λR=KR/K.
h2 =
T − TR
√
1− (1− T/i) (T 2 − T 2R)
aR
(
i + (i − T )T 2R
) (A4)
We use Eq. A4 for estimation of heritability and Eq. A2 for esti-
mation of an approximate standard error (using the h2 from
Eq. A4 for situations where the relatives and probands have the
same disorder and the cohort of relatives are associated with only
one affected proband. These methods are generalized for different
circumstances below (II)–(V).
(II) Offspring affected and both parents affected – offspring and
parents have the same disorder
TR = T − ih
2√
1− 0.5h4i(i − T ) ;
h2 = 2T −√2TR
√
2− (T 2 − TR)(1− Ti )
2i + (i − T )TR ;
s.e fromEq. A2 with aR set to 1.
(III) Relatives have one disease (c) probands have another (f).
We assumed that the heritability of diseases c and f are h2c and h
2
f
respectively, and the genetic correlation between them is rcf, then
eqs A3 and A4 generalize to
TRc =
Tc − aR if rcf hchf√
1− a2Rr2cf h2c if
(
if − Tf
) ;
rcf hchf =
T − TR
√
1− (1− Tf /if ) (T 2f − T 2Rc)
aR
(
if +
(
if − Tf
)
T 2Rc
) and
s.e
(
rcf hchf
) ≈ 1
aR
×
√√√√[K 2f
y2f
(
1
if
+ aRrcf hchf
(
if − Tf
))2 + 1
i2f
(
K 2Rc
y2Rc
+ K
2
c
y2c
)]
,
(A5)
(IV) Offspring have one disorder (c) and both parents have the
same but other disorder (f).
TRc =
Tc − if rcf hchf√
1− 0.5r2cf h2c if
(
if − Tf
) ;
rcf hchf = 2Tc −
√
2TRc
√
2− (1− Tf /if ) (T 2c − T 2Rc)
2if +
(
if − Tf
)
T 2Rc
and s.e (rcf hc hf) asEq. A5 but with aR set equal to 1.
Since the scenario is relatively rare the resulting estimates
have high standard errors and so have little impact on a
weighted average with the estimate from a single affected
parent.
(V) Offspring have disorder (c), one parent also has disorder c
but the other parent has another disorder (f).
In this case
TRc =
Tc − 0.5rcf hchf if − 0.5h2c i2c√
1− 0.25r2cf h2f h2c if
(
if − Tf
)− 0.25h4c ic (ic − Tc ) (A6)
Solving for rcf hc hf creates and expression dependent on h
2
c so
estimates of genetic correlation from this type of data have not
been achieved.
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CONFIDENCE INTERVALS OF RATIOS
95% CI of recurrence risk ratio calculated from 95% CI of
numerator (x1± s1) and denominator (x2± s2):
(x1 ± s1)÷ (x2 ± s2) = x1
x2
± x1
x2
√
s21
x21
+ s
2
2
x22
WEIGHTING BY SAMPLING VARIANCE
When there are n estimates of the same parameter, i.e., x1..xn each
with standard error si for i= 1,. . .n. Then the overall estimate x ± s
weights the different estimates by their sampling variance,
x =
n∑
i=1
xi
s2i
n∑
i=1
s2i
, s = 1/
√√√√ n∑
i=1
1
s2i
ESTIMATES OF GENETIC CORRELATIONS
For completeness, we provide the estimates of genetic correla-
tions calculated from the Danish summary data. Based on our
simulation results these estimates are consistent with a genetic cor-
relation greater than zero. However, we believe it is not possible to
separate out the impact of the double counting of diagnoses. In
addition, these estimates may be inflated by contributions of com-
mon environmental factors. For these reasons we do not consider
the estimates to be reliable.
Firstly, for comparison the estimate of the genetic correla-
tion between schizophrenia and bipolar disorder reported in the
Swedish study (Lichtenstein et al., 2009) was 0.60 (no 95% CI
reported),whereas based on the summary statistics from that study
we estimated the genetic correlation to be 0.47 (95% CI 0.42–0.52).
In preliminary analyses for the Gottesman et al. (2010) arti-
cle the authors calculated cumulative incidences up to age 51 and
for a different (but overlapping) set of relative types. Here we use
the previously unpublished estimates to age 51 because, firstly,
this set allowed us to estimate the genetic correlation between
schizophrenia and MDD, which was not possible from the pub-
lished estimates. Secondly,while the published results allowed us to
estimate the genetic correlation between schizophrenia and bipo-
lar disorder the estimates were based on cumulative incidence of
one disorder in children where both parents had the other disor-
der. In contrast, the unpublished results allowed us to estimate this
genetic correlation from cumulative incidence of schizophrenia in
children where one parent has bipolar disorder; since this event
is more prevalent the resulting estimate of the genetic correlation
has a lower standard error. Results are presented in Table A1.
Simulations that generate prevalence rates and heritabilities
consistent with the empirical estimates based on the summary
data to age 51 years are presented in Table A2. Simulation sce-
nario in row 3 shows that in the absence of random misdiagnosis
but with a true genetic correlation of 0.47 between schizophre-
nia and bipolar disorder, that 7.5% of those with a diagnosis
of schizophrenia and 14.7% of those with a diagnosis of bipo-
lar disorder would qualify also for the diagnosis of the other
disorder, demonstrating that dual diagnosis is consistent with a
positive correlation between the disorders. Simulation scenarios
in rows 4 and 5 consider the genetic correlation resulting under
random misdiagnosis/double counting of disorders. Simulation
scenario 6 shows the parallel scenario to the row 3 simulation,
but is based on empirical estimates for schizophrenia and MDD.
A true genetic correlation that matches the empirical estimate
of 0.42, was consistent with 24% of those with schizophrenia
and 7.1% of those diagnosed with major depression would also
be diagnosed with the other disorder. In simulations, we were
unable to generate the empirical estimate of the genetic corre-
lation by manipulating the misdiagnosis rate and heritability of
schizophrenia while assuming the true genetic correlation and the
MDD misdiagnosis rate to be zero. However, to report 0.42 as the
genetic correlation between SCZ and MDD would be misleading
as we cannot disentangle contributions of the effects of common
environment.
Table A1 | Estimates of genetic parameters using cumulative incidences to age 51 estimated from national records of the Danish population.
Child Parents Cumulative incidence 95% CI Genetic parameter Estimate 95% CI
SCZ ALL 0.0114 0.0112–0.0117
BPD ALL 0.0058 0.0055–0.0060
MDD ALL 0.0390 0.0384–0.0395
SCZ SCZ/- 0.0689 0.0629–0.0750 h2SCZ 0.66 0.63–0.70
SCZ SCZ/SCZ 0.2734 0.1841–0.3627 h2SCZ 0.65 0.55–0.76
Weighted mean heritability of schizophrenia h2SCZ 0.66 0.63–0.70
BPD BPD/- 0.0415 0.0373–0.0457 h2BPD 0.61 0.57–0.64
BPD BPD/BPD 0.2298 0.1242–0.3354 h2BPD 0.65 0.54–0.77
Weighted mean heritability of bipolar disorder h2BPD 0.61 0.58–0.65
MDD MDD/- 0.0743 0.0717–0.0770 h2MDD 0.31 0.29–0.33
MDD MDD/MDD 0.1466 0.1223–0.1708 h2MDD 0.34 0.31–0.39
Weighted mean heritability of MDD h2MDD 0.31 0.29–0.33
SCZ BPD/- 0.0299 0.0270–0.0328 rSCZ-BPDhSCZhBPD 0.29 0.26–0.32
Genetic (familial) correlation between schizophrenia and bipolar disorder rSCZ-BPD 0.47 0.42–0.52
SCZ MDD/- 0.0194 0.0182–0.0206 rSCZ-MDDhSCZhMDD 0.20 0.18–0.23
Genetic (familial) correlation between schizophrenia and MDD rSCZ-MDD 0.46 0.40–0.52
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Table A2 | Simulation results with simulation parameters selected to generate estimated diagnosis prevalence rates and heritabilities based on
cumulative incidences up to 51 years.
True (simulation) parameters Estimated parameters (95% Confidence intervals)
Prevalence h2 rg Misdiagnosis both
diagnoses counted
rg Proportion with alternate diagnosis
SCZ Other SCZ Other SCZ Other SCZ Other
0.0114 0.0058 0.66 0.61 0 0 0 0.00 (−0.06−0.07) 0.006 (0.005–0.006) 0.011 (0.010–0.013)
0.0110 0.0055 0.66 0.61 0 0.028 0.071 0.18 (0.11–0.23) 0.075 (0.072–0.078) 0.147 (0.142–0.153)
0.0114 0.0058 0.66 0.61 0.47 0 0 0.47 (0.41–0.51) 0.075 (0.071–0.078) 0.147 (0.141–0.152)
0.0110 0.0055 0.67 0.63 0.39 0.028 0.071 0.47 (0.42–0.52) 0.106 (0.103–0.111) 0.209 (0.202–0.215)
0.0107 0.0052 0.70 0.66 0 0.056 0.142 0.31 (0.25–0.37) 0.121 (0.118–0.124) 0.238 (0.232–0.243)
0.0114 0.0390 0.66 0.31 0.46 0 0 0.46 (0.42–0.50) 0.244 (0.239–0.247) 0.071 (0.070–0.073)
For simulations in rows 1–5 the estimated diagnosis prevalence rates are 0.0114 and 0.0058, and estimated heritabilities are 0.66 and 0.61, matching the empirical
results for schizophrenia and bipolar disorder respectively. For the simulation in row 6 the estimated diagnosis prevalence rates are 0.0114 and 0.0390, and estimated
heritabilities are 0.66 and 0.31, matching the empirical results for schizophrenia and MDD respectively.
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